BioInvent International AB (publ) BOVNF
0.44 USD -0.17 (-27.16%)
At closeNov 2, 2026, 4:00 PM EST
0.3995 Day range 0.3995
0.3995 52-week range 3.29
- YTD
- -86.50%
- 1 year
- -86.50%
- Market cap
- 29.22M
- EPS (ttm)
- -0.88
- YTD return
- -86.50%
- 1-year return
- -86.50%
- Volume
- 2.50K
- Avg volume
- 187
- Open
- 0.3995
- Previous close
- 0.6097
- Day's range
- 0.3995 – 0.3995
- 52-week range
- 0.3995 – 3.29
3M -2.8905 (-87.86%)
News
BioInvent International AB (publ) (BOVNF) Q3 2026 Earnings Call Transcript 
BioInvent To Present BI-1808 Data in Platinum-Resistant Recurrent Ovarian Cancer at ESMO 2026 
BioInvent International AB Announces that its CFO will Retire in 2027 
BioInvent International AB (publ) (BOVNF) Discusses Ovarian Cancer Treatment Landscape and TNFR2-Targeted Therapies in Solid Tumors Transcript 
BioInvent to Host Virtual KOL Event to Discuss BI-1808 for the Treatment of Ovarian Cancer, on May 27, 2026 
Resolutions at BioInvent's Annual General Meeting 2026 
BioInvent to Host Two Key Opinion Leader Events Highlighting Progress Across Oncology Portfolio 
BioInvent International AB: Interim Report January - March 2026 
BioInvent to Present Data of BI-1808 Plus KEYTRUDA(R) (Pembrolizumab) in Recurrent Ovarian Cancer at the 2026 ASCO Annual Meeting 
BioInvent International AB Publishes Annual Report 2025
Your note
Sign in to keep a note on BOVNF — it syncs with the Stock Master app.